Intended for healthcare professionals

Practice

Update to living WHO guideline on drugs for covid-19

BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4475 (Published 20 November 2020) Cite this as: BMJ 2020;371:m4475

Read our latest coverage of the coronavirus outbreak

This living guideline by Lamontagne and colleagues (BMJ 2020;370:m3379) has been updated. For the latest update, visit doi:10.1136/bmj.m3379. The latest version of this WHO living guidance focuses on remdesivir, following the 15 October 2020 preprint publication of results from the WHO SOLIDARITY trial. It contains a weak or conditional recommendation against the use of remdesivir in hospitalised patients with covid-19.

View Abstract